NCT04711382View on ClinicalTrials.gov

The Use of Faster Acting Aspart in Type 1 Diabetes Patients

CompletedOBSERVATIONAL
Enrollment

438

Participants

Timeline

Start Date

January 29, 2018

Primary Completion Date

December 14, 2020

Study Completion Date

January 1, 2021

Conditions
Type 1 DiabetesInsulinTime in Range
Trial Locations (1)

2650

Antwerp University Hospital, Edegem

All Listed Sponsors
collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

lead

University Hospital, Antwerp

OTHER

NCT04711382 - The Use of Faster Acting Aspart in Type 1 Diabetes Patients | Biotech Hunter | Biotech Hunter